Exact Mass: 1187.5516912

Exact Mass Matches: 1187.5516912

Found 13 metabolites which its exact mass value is equals to given mass value 1187.5516912, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Eledoisin

Eledoisin acetate salt

C54H85N13O15S (1187.60085)

D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D018377 - Neurotransmitter Agents > D015320 - Tachykinins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms Eledoisin (Eledone peptide) is a specific agonist of NK2 and NK3 receptors.

Antigonadotropic decapeptide

1-(2-{2-[2-(6-amino-2-{2-[2-({1-[2-(2-amino-3-hydroxypropanamido)-3-phenylpropanoyl]pyrrolidin-2-yl}formamido)-3-hydroxybutanamido]-3-hydroxybutanamido}hexanamido)-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido}-3-phenylpropanoyl)pyrrolidine-2-carboxylic acid

C58H81N11O16 (1187.5862466)

Eledoisin

3-[6-amino-2-(3-hydroxy-2-{[1-(5-oxopyrrolidine-2-carbonyl)pyrrolidin-2-yl]formamido}propanamido)hexanamido]-3-({1-[(1-{[1-({[(1-{[1-carbamoyl-3-(methylsulfanyl)propyl]carbamoyl}-3-methylbutyl)carbamoyl]methyl}carbamoyl)-2-methylbutyl]carbamoyl}-2-phenylethyl)carbamoyl]ethyl}carbamoyl)propanoic acid

C54H85N13O15S (1187.60085)

largamide E

C56H82ClN9O17 (1187.5516912)

A 19-membered cyclodepsipeptide isolated from the marine cyanobacterium Oscillatoria sp. It exhibits significant inhibitory activity against the enzyme chymotrypsin (EC 3.4.21.1).

C66H77NO19

C66H77NO19 (1187.5089532)

3-oxooctacosanoyl-CoA

C49H88N7O18P3S (1187.5119138)

S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2S,4S,6S)-2,4,6-trimethylhexacosanethioate

S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2S,4S,6S)-2,4,6-trimethylhexacosanethioate

C50H92N7O17P3S (1187.5482972)

H-DL-Ser-DL-Phe-DL-Pro-DL-xiThr-DL-xiThr-DL-Lys-DL-xiThr-DL-Tyr-DL-Phe-DL-Pro-OH

C58H81N11O16 (1187.5862466)

C29:0-CoA; (Acyl-CoA); [M+H]+

C50H92N7O17P3S (1187.5482972)

3-oxomontanoyl-CoA

C49H88N7O18P3S (1187.5119138)

A 3-oxo-fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-oxomontanoic acid.

(2s)-n-[(1s)-1-{[(1s)-1-{[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-2-[(1s)-1-hydroxyethyl]-8-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl]-c-hydroxycarbonimidoyl}ethyl]-5-(4-hydroxyphenyl)-2-{[(2r)-1,2,3-trihydroxypropylidene]amino}pentanimidic acid

(2s)-n-[(1s)-1-{[(1s)-1-{[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-2-[(1s)-1-hydroxyethyl]-8-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl]-c-hydroxycarbonimidoyl}ethyl]-5-(4-hydroxyphenyl)-2-{[(2r)-1,2,3-trihydroxypropylidene]amino}pentanimidic acid

C56H82ClN9O17 (1187.5516912)

(2s)-n-[(1r)-1-{[(1s)-1-{[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-2-[(1r)-1-hydroxyethyl]-8-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl]-c-hydroxycarbonimidoyl}ethyl]-5-(4-hydroxyphenyl)-2-{[(2r)-1,2,3-trihydroxypropylidene]amino}pentanimidic acid

(2s)-n-[(1r)-1-{[(1s)-1-{[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-2-[(1r)-1-hydroxyethyl]-8-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl]-c-hydroxycarbonimidoyl}ethyl]-5-(4-hydroxyphenyl)-2-{[(2r)-1,2,3-trihydroxypropylidene]amino}pentanimidic acid

C56H82ClN9O17 (1187.5516912)

n-(1-{[1-({5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-2-(1-hydroxyethyl)-8-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-c-hydroxycarbonimidoyl)-2-methylpropyl]-c-hydroxycarbonimidoyl}ethyl)-5-(4-hydroxyphenyl)-2-[(1,2,3-trihydroxypropylidene)amino]pentanimidic acid

n-(1-{[1-({5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-2-(1-hydroxyethyl)-8-isopropyl-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-c-hydroxycarbonimidoyl)-2-methylpropyl]-c-hydroxycarbonimidoyl}ethyl)-5-(4-hydroxyphenyl)-2-[(1,2,3-trihydroxypropylidene)amino]pentanimidic acid

C56H82ClN9O17 (1187.5516912)